ROME (AP) — Moderna’s chairman says the company has no plans to share the recipe for its COVID-19 vaccine as executives have concluded that scaling their own production is the best way to improve the global footprint. To increase supply.
Interview with The Associated PressNoubar Afeyan also reaffirmed a promise Moderna made last year not to enforce patent infringement on anyone else creating a coronavirus vaccine for the pandemic.
Afeyan said to the AP that they didn’t have a choice. “We believe that this was the responsible, right way to do it.” He said, “We want to do that to help all people.”
Moderna has been pressured by the United Nations Health Agency to share its vaccine formulation.
Afeyan stated that the company examined whether it would make sense to share messengerRNA technology. It determined that it could increase production and deliver billions more doses by 2022.
Afeyan stated that Moderna’s COVID-19 vaccination was developed by the team that spent $2.5 billion over 10 years.
“Others joined the hunt when COVID-19 occurred, and we are pleased to see that capacity has therefore increased significantly beyond what Moderna could have done on its own,” Afeyan told the AP.